Research Paper Volume 15, Issue 16 pp 8325—8344
Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis
Figure 12. Analyses of immunological features and immunotherapy response. (A) Heatmap showed the expression of immune cells between low- and high-risk groups. (B) Enrichment levels of immune-related cells and types between the low- and high-risk groups in the heatmap. (C) Differences in immune cells between two groups. (D) Differences in immune function between two groups. (E–H) Comparison of immune score, stromal score, ESTIMATE score, and tumor purity between two groups. (I) Differences in immune checkpoint expression between two groups. (J) TIDE comparison between low- and high-risk groups. * P<0.05, ** P<0.01, *** P<0.001.